Prevalence of Chronic Rhinosinusitis, Germ-colonisation and Ability to Smell in Cystic Fibrosis

The recruitment status of this study is unknown because the information has not been verified recently.

Verified December 2010 by University of Jena.
Recruitment status was Recruiting

Sponsor:

Information provided by:

University of Jena

ClinicalTrials.gov Identifier:

NCT00803881

First received: December 5, 2008

Last updated: December 7, 2010

Last verified: December 2010

History of Changes

Tracking Information

First Received Date ^ICMJE

December 5, 2008

Last Updated Date

December 7, 2010

Start Date ^ICMJE

December 2008

Estimated Primary Completion Date

June 2011 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT00803881 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Prevalence of Chronic Rhinosinusitis, Germ-colonisation and Ability to Smell in Cystic Fibrosis

Official Title ^ICMJE

Prevalence of Chronic Rhinosinusitis, Germ-colonisation in the Upper and Lower Airways and Ability to Smell in Cystic Fibrosis

Brief Summary

Aim of the study is to detect the prevalence of chronic rhinosinusitis,the germ colonisation of the lower and upper airways and the ability to smell in patients with cystic fibrosis.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Case-Only

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Non-Probability Sample

Study Population

patients of the CF outpatients clinic

Condition ^ICMJE

Cystic Fibrosis
Sinusitis

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

Estimated Completion Date

June 2011

Estimated Primary Completion Date

June 2011 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Subject has a confirmed diagnosis of cystic fibrosis

Exclusion Criteria:

Current systemic therapy against Pseudomonas aeruginosa

Gender

Both

Ages

6 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: Jochen Mainz, MD

+49 3641 938425

Jochen.Mainz@med.uni-jena.de

Location Countries ^ICMJE

Germany

Administrative Information

NCT Number ^ICMJE

NCT00803881

Other Study ID Numbers ^ICMJE

CF_Sinusitis_LS

Has Data Monitoring Committee

Responsible Party

Jochen Mainz, MD, University of Jena - CF Center

Study Sponsor ^ICMJE

University of Jena

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Study Chair:

Jochen Mainz, MD

University of Jena - CF Center

Information Provided By

University of Jena

Verification Date

December 2010

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top